CK2 modulation of NF-κB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules
Matthew S. Brown, Oumou T. Diallo, Michael Hu, Reza Ehsanian, Xinping Yang, Pattatheyil Arun, Hai Lu, Vicci Korman, Gretchen Unger, Khalil Ahmed, Carter Van Waes, Zhong Chen
Dive into the research topics of 'CK2 modulation of NF-κB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules'. Together they form a unique fingerprint.